Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Share News (ABC)

  • There is currently no data for ABC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Abcam Acquires Expedeon's Proteomics And Immunology Businesses

Mon, 11th Nov 2019 09:00

(Alliance News) - Abcam PLC on Monday said it has agreed to buy proteomics and immunology businesses of Expedeon AG for EUR120 million on a cash and debt free basis.

The acquisition comprises of Expedeon Ltd, Innova Biosciences Ltd and TGR BioSciences.

The protein research tools distributor said it expects the acquisition to accelerate its "strategic ambition" within the antibody conjugation and labelling market as well as to combine Expedeon and Abcam's technologies to create new products.

Abcam said it will fund the purchase from a drawdown of its revolving credit facility and existing cash resources.

The transaction is, however, subject to approval by Expedeon shareholders at a general meeting to be held on December 19. If approved, the acquisition is expected to close in early 2020, Abcam said.

For 2018, Expedeon's revenue was EUR13.1 million, adjusted earnings before interest, taxes, depreciation, and amortisation was EUR1.0 million and net assets stood at EUR46.5 million.

"Abcam's growth strategy is committed to building out conjugation and assay capabilities. Expedeon's portfolio of products and technology, combined with Abcam's antibody and protein strengths, will put our company in a strong position to address the growing need for antibody conjugation and multiplexing solutions," said Chief Executive Alan Hirzel.

We look forward to taking these innovation capabilities to market to provide a broader array of distinctive products for our customers," Hirzel added.

Abcam shares were trading 0.3% higher in London on Monday at 1,255.00 pence each.

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
25 Jul 2016 15:15

Abcam describes 'another successful year' ahead of results

(ShareCast News) - Life science research tools supplier Abcam posted a trading update for the year to 30 June on Monday, ahead of the publication of its financial results, due 12 September. The AIM-traded firm described "another successful year" and claimed to have achieved above market revenue grow

Read more
20 Jun 2016 15:35

Abcam announces Wood as new finance chief

(ShareCast News) - Life science research tools firm Abcam announced on Monday the appointment of Gavin Wood as its chief financial officer. The AIM-traded firm said Wood, who is the former executive vice president and CFO of Affymetrix, is to join the company on 18 July and succeed Jeff Iliffe after

Read more
20 Jun 2016 06:40

Abcam Appoints Gavin Wood As New Chief Financial Officer

Read more
5 Apr 2016 08:32

BROKER RATINGS SUMMARY: Liberum Upgrades Babcock To Hold From Sell

Read more
14 Mar 2016 09:33

BROKER RATINGS SUMMARY: HSBC And Merrill Lynch Downgrade Admiral

Read more
10 Mar 2016 16:13

Dividends Calendar - Week Ahead

Read more
7 Mar 2016 14:30

Abcam shares sink on news of lower earnings

(ShareCast News) - Abcam tried to paint its interim results as strong on Monday, with the biotechnology company making increased investment for the future, though the market did not agree in afternoon trading. The AIM-traded firm saw revenue rise 17.2% on a constant currency basis and 18% on a repor

Read more
7 Mar 2016 07:51

Abcam Confident In Meeting Full-Year Targets As COO To Retire

Read more
29 Feb 2016 16:08

Earnings, Trading Statements Calendar - Week Ahead

Read more
26 Jan 2016 09:43

BROKER RATINGS SUMMARY: UBS Upgrades RBS To Buy From Neutral

Read more
25 Jan 2016 10:36

Avacta Poaches Abcam's Cotrel For Chief Commercial Officer Role

Read more
25 Jan 2016 07:56

Abcam Expects Revenue Growth Of 17% For First Half

Read more
5 Jan 2016 09:43

BROKER RATINGS SUMMARY: S&P CapIQ Cuts Next To Buy From Strong Buy

Read more
27 Nov 2015 15:44

Dividends Calendar - Week Ahead

Read more
11 Nov 2015 16:40

DIRECTOR DEALINGS: Abcam CEO Buys GBP19,343 Of Stock After AxioMx Deal

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.